Seelos Therapeutics, Inc. (SEEL)
NASDAQ: SEEL · Real-Time Price · USD
2.430
-0.040 (-1.62%)
Oct 11, 2024, 4:00 PM EDT - Market closed
Seelos Therapeutics Employees
As of December 31, 2023, Seelos Therapeutics had 16 total employees, including 15 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$125,875
Profits / Employee
$255,688
Market Cap
1.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 16 | 0 | - |
| Dec 31, 2022 | 16 | 0 | - |
| Dec 31, 2021 | 16 | 6 | 60.00% |
| Dec 31, 2020 | 10 | 4 | 66.67% |
| Dec 31, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aditxt | 47 |
| LogicMark | 27 |
| Genprex | 26 |
| Windtree Therapeutics | 20 |
| Catheter Precision | 14 |
| Revelation Biosciences | 9 |
| Entero Therapeutics | 9 |
| PainReform | 7 |
SEEL News
- 15 days ago - Seelos Announces Postponement of its Annual Meeting of Stockholders - PRNewsWire
- 17 days ago - Seelos Therapeutics Announces 1-for-16 Reverse Stock Split - PRNewsWire
- 18 days ago - Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD - PRNewsWire
- 5 months ago - Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - PRNewsWire
- 5 months ago - Seelos Therapeutics Announces 1-for-8 Reverse Stock Split - PRNewsWire
- 5 months ago - Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations - PRNewsWire
- 7 months ago - Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose) - PRNewsWire
- 9 months ago - Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - PRNewsWire